equityflowunderstand the flow and follow it
EquityFlow › Companies › Alpha Fusion

Alpha Fusion

Biotech · Osaka, JP

Targeted alpha therapy (astatine At-211) for cancer treatment

In the network

Shares the most investors with (number = shared investors):
Trinity Technology 2

Funding history

DateRoundAmount
Oct 2024Series B
Alpha Fusion, an astatine targeted-alpha-therapy startup, raised 1.02B JPY in Series B co-led by SBI Investment and Osaka University VC, with Mitsui Mining & Smelting, Kobe University Capital and Joyo Capital Partners as new investors.
$6.7M

Investors

Tap an investor to see what else they have backed.

Joyo Capital PartnersKobe University CapitalMitsui Mining & SmeltingOsaka University Venture CapitalSBI Investment

Other companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca

Other companies in JP

PayPayRapidusMWAracanSmart CraftHerLifeLabTokenzDubGuildDJ InsightSnack TechnologiesNekonomeLinQ

Other companies at Series B stage

0x Labs11x.ai1K Kirana1X Technologies1plusX3Commas3SC4baseCare4screen8fig9finACALL
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.